Iria Vázquez Urio

Profesora Ayudante Doctor

Public University of Navarre

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Science Medical Science professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Iria Vázquez Urio is an Assistant Professor at the Public University of Navarre in Spain. Her research focuses on the molecular diagnostics and genomic profiling of hematological malignancies, particularly in the context of multiple myeloma and acute myeloid leukemia. Recent articles highlight her work on next-generation sequencing and its implications for personalized treatment strategies, as well as the assessment of minimal residual disease in myeloid neoplasms.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Cristina Jiménez

SPAIN

View details

Sara Villar

Clinica Universidad de Navarra

SPAIN

View details

ROSA MARIA AYALA DIAZ

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Felipe de Arriba de la Fuente

Profesor Asociado

Universidad de Murcia

SPAIN

View details

Sara Palomino-Echeverria

Associate Professor

Universidad de Navarra

SPAIN

View details

Juan Manuel Alonso-Dominguez

Universidad Autónoma de Madrid

SPAIN

View details

María Carmen Chillón

SPAIN

View details

MJ Calasanz

Full Professor of Genetics

Universidad de Navarra

SPAIN

View details

Enrique M. Ocio

SPAIN

View details

Norma C. Gutiérrez

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Iria Vázquez Urio

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia.

NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial

Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study

Whole Exome Sequencing or Pan-Myeloid NGS Gene Panel to Assess Leukemic Evolution of Myelodysplastic Syndromes. Advantages and Disadvantages

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

Strategy for identification of a potential inherited leukemia predisposition in a 299 patient’s cohort with tumor-only sequencing data

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

Collaborators (10)

Cristina Jiménez

Sara Villar

ROSA MARIA AYALA DIAZ

Felipe de Arriba de la Fuente

Sara Palomino-Echeverria

Juan Manuel Alonso-Dominguez

María Carmen Chillón

MJ Calasanz

Enrique M. Ocio

Norma C. Gutiérrez

Make your next move.